5,5''-Dibromo-3,3''-dihexyl-2,2':5',2''-terthiophene, 97%, 1g

6,10-Dioxaspiro[4.5]decane-7,9-dione, 95.0%, 250mg

tert-Butyl 2,6-diazaspiro[3.5]nonane-2-carboxylate hemioxalate, 97%, 1g

5-Butyldihydrofuran-2(3H)-one, 95.0%, 5g

(Z)-3,7-Dimethylocta-2,6-dien-1-yl acetate, 95.0%, 5g

(R)-1-Boc-2-Methyl-pyrrolidine, 95.0%, 5g

4-Bromo-1-(4-chlorophenyl)-1H-pyrazole, 97%, 5g

(AC-CYS-OH)2, 90.0%, 250mg

1'-Boc-5-Fluoro-1,2-dihydro-2-oxo-spiro[3H-indole-3,4'-piperidine], 95.0%, 1g

5-Chloro-2-thiophenecarboxylic acid N-methylamide, 97%, 25mg

Electroporation cuvettes 850 µl, 10 pcs 10 pcs

9,10-Dichloroanthracene>96.0%(GC)10g

1-(3-Bromophenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 5g